Dr. Thierry Coppola is currently affiliated with Centre National de la Recherche
Scientifique (CNRS), Université Côte d’Azur. He completed his Ph.D. studies in
Prof. Michel Lazdunski’s lab, working on the molecular characterization of
voltage-dependent calcium channels. He was a post-doctoral fellow under
Prof. Cameron Gundersen at UCLA Dept of Pharmacology, working on Cysteine
String Protein (CSP), a chaperone protein associated with synaptic vesicles. He
has focused his research on neurotransmitter and insulin secretion machinery.
His interests include neurotensin, beta cell insulin-secreting cells, G-protein-
coupled receptors, sortilin, receptors, insulin secretion, calcium signaling,
potassium channel blockers, exocytosis, and islets of Langerhans.
Dr. Nicolas Blondeau is the Research Director at the CNRS,
located in France. He has long-lasting and recognized expertise in the
science of stroke and the search for new treatments, with strong
links with national and international networks, especially as the Secretary of
the International Society for Blood Flow & Metabolism—a predominant
international society in the stroke/brain ischemia field. He has also served on
several journal editorial boards and research advisory panels, including those
of the E.U. Commission, French ANR, Swiss National Science Foundation, NSC
Poland, MIUR Italy, and TIBITAK Turkey. He has developed strong experience with
issues related to the neuroprotective moiety itself and its contribution to clinical
trial failures—which include late delivery, mono-targeting, low potency and
poor tolerability—establishing a new concept in the field that neurons could be
preconditioned/protected by nutraceuticals that are gaining increasing
attention, especially in the PharmaNutrition field, as potential approaches to
protect the brain.
